Loading…

🏦 Mutual Funds

Browse India's complete AMFI-registered mutual fund universe — official daily NAV, trailing returns, and category peer rankings, updated every day.

Coverage note: We track the complete AMFI-registered universe (4,200+ schemes) for official NAV and returns, sourced directly from AMFI's daily feed. Deeper profile data — AUM, expense ratio, holdings — is available for a limited subset of funds.
Clear all
Fund AMC Category Plan 1Y 3Y CAGR Category Rank Latest NAV Profile Data
ITI Bharat Consumption Fund ITI Mutual Fund Equity Regular +2.05% 116/159 (Top 73%) 11.7654
ITI Business Cycle Fund ITI Mutual Fund Equity Direct 10.5962
ITI Business Cycle Fund ITI Mutual Fund Equity Regular 10.5046
ITI Dynamic Term Fund ITI Mutual Fund Income/Debt Oriented Regular +2.58% +5.20% 22/22 (Top 100%) 12.7642
ITI Dynamic Term Fund ITI Mutual Fund Income/Debt Oriented Direct +3.62% +6.29% 20/21 (Top 95%) 13.4714
ITI ELSS Tax Saver Fund ITI Mutual Fund Equity Direct +9.85% +18.06% 4/19 (Top 21%) 29.1617
ITI ELSS Tax Saver Fund ITI Mutual Fund Equity Regular +7.91% +15.96% 4/19 (Top 21%) 25.4812
ITI Flexi Cap Fund ITI Mutual Fund Equity Regular +14.40% +17.15% 2/41 (Top 5%) 20.0800
ITI Flexi Cap Fund ITI Mutual Fund Equity Direct +16.11% +19.09% 2/41 (Top 5%) 21.3222
ITI Focused Fund ITI Mutual Fund Equity Direct +13.31% +19.40% 4/28 (Top 14%) 17.5740
ITI Focused Fund ITI Mutual Fund Equity Regular +11.29% +17.24% 4/28 (Top 14%) 16.5697
ITI Large & Mid Cap Fund ITI Mutual Fund Equity Direct +7.45% 19/33 (Top 58%) 10.2978
ITI Large & Mid Cap Fund ITI Mutual Fund Equity Regular +5.72% 20/33 (Top 61%) 9.9623
ITI Large Cap Fund ITI Mutual Fund Equity Regular +0.59% +9.05% 17/32 (Top 53%) 17.2507
ITI Large Cap Fund ITI Mutual Fund Equity Direct +2.38% +11.08% 15/32 (Top 47%) 19.3258
ITI Liquid Fund ITI Mutual Fund Debt Regular +6.05% +6.57% 24/31 (Top 77%) 1,456.8282
ITI Liquid Fund ITI Mutual Fund Debt Direct +6.18% +6.73% 21/26 (Top 81%) 1,471.4944
ITI Mid Cap Fund ITI Mutual Fund Equity Regular +14.30% +19.46% 4/30 (Top 13%) 23.5614
ITI Mid Cap Fund ITI Mutual Fund Equity Direct +16.12% +21.51% 4/30 (Top 13%) 26.1969
ITI Multi Cap Fund ITI Mutual Fund Equity Direct +15.82% +18.16% 5/31 (Top 16%) 30.3759
ITI Multi Cap Fund ITI Mutual Fund Equity Regular +14.11% +16.27% 5/32 (Top 16%) 26.4360
ITI Overnight Fund ITI Mutual Fund Debt Direct +5.04% +5.87% 24/25 (Top 96%) 1,391.3179
ITI Overnight Fund ITI Mutual Fund Debt Regular +4.94% +5.76% 23/24 (Top 96%) 1,381.8125
ITI Pharma and Healthcare Fund ITI Mutual Fund Equity Direct +15.47% +20.95% 42/159 (Top 26%) 20.0303
ITI Pharma and Healthcare Fund ITI Mutual Fund Equity Regular +13.39% +18.72% 48/159 (Top 30%) 18.2022

NAV and returns are historical data, not a recommendation. Past performance does not guarantee future returns.
Official NAV data sourced from AMFI, updated daily.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including equities and mutual funds, involves inherent risks, including the potential loss of principal. All investments are subject to market fluctuations, regulatory changes, and other risks that may affect their value. Past performance is not indicative of future results. This report is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This report does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a SEBI-registered investment adviser or other qualified financial professional before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities or financial instruments discussed in this report. Any such positions, if material, are disclosed to the best of the author's knowledge and are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company, institution, or third party.

Information Sources:
The analysis and opinions expressed herein are based on publicly available information, including but not limited to company filings with the BSE/NSE, annual reports, management commentary, investor presentations, data from the Reserve Bank of India (RBI), SEBI, industry publications, and other reliable financial data sources. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This report may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. The author does not undertake any obligation to update such statements in the future.

Regulatory Compliance:
This report is intended to comply with the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, as amended, and other applicable Indian laws and regulations.

Limitation of Liability:
The content of this report is provided "as is" without any warranties, express or implied, including accuracy, completeness, merchantability, or fitness for a particular purpose. The author and publisher expressly disclaim any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.